BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 22524200)

  • 1. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment.
    Awan Kh; Yang Y; Morgan P; Warnakulasuriya S
    Oral Dis; 2012 Nov; 18(8):728-33. PubMed ID: 22524200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses.
    Awan KH; Morgan PR; Warnakulasuriya S
    J Oral Pathol Med; 2011 Aug; 40(7):541-4. PubMed ID: 21615500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
    Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
    Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses.
    Awan KH; Morgan PR; Warnakulasuriya S
    Oral Oncol; 2011 Apr; 47(4):274-7. PubMed ID: 21396880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation.
    Awan KH; Morgan PR; Warnakulasuriya S
    Clin Oral Investig; 2015 Dec; 19(9):2267-72. PubMed ID: 25804887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions.
    Nagaraju K; Prasad S; Ashok L
    Indian J Dent Res; 2010; 21(2):218-23. PubMed ID: 20657091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions.
    Chainani-Wu N; Madden E; Cox D; Sroussi H; Epstein J; Silverman S
    Oral Dis; 2015 Oct; 21(7):879-85. PubMed ID: 26173924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions.
    Ram S; Siar CH
    Int J Oral Maxillofac Surg; 2005 Jul; 34(5):521-7. PubMed ID: 16053872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
    Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
    J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of toluidine blue in the detection of pre-malignant and malignant oral lesions.
    Cancela-Rodríguez P; Cerero-Lapiedra R; Esparza-Gómez G; Llamas-Martínez S; Warnakulasuriya S
    J Oral Pathol Med; 2011 Apr; 40(4):300-4. PubMed ID: 21426401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of chemiluminescence and toluidine blue in the diagnosis of dysplasia in leukoplakia: a cross-sectional study.
    Chaudhry A; Manjunath M; Ashwatappa D; Krishna S; Krishna AG
    J Investig Clin Dent; 2016 May; 7(2):132-40. PubMed ID: 25532724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions.
    Güneri P; Epstein JB; Kaya A; Veral A; Kazandı A; Boyacioglu H
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):155-61. PubMed ID: 21112183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autofluorescence and early detection of mucosal lesions in patients at risk for oral cancer.
    Moro A; Di Nardo F; Boniello R; Marianetti TM; Cervelli D; Gasparini G; Pelo S
    J Craniofac Surg; 2010 Nov; 21(6):1899-903. PubMed ID: 21119451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas.
    Onofre MA; Sposto MR; Navarro CM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):535-40. PubMed ID: 11346731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical evaluation of Oratest in detecting oral mucosal lesions].
    Cheng B; Yang L
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):124-6. PubMed ID: 12838698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [White lesions of the oral mucosa. Auxiliary diagnostic methods].
    Amorin C; Caffarena MP
    An Fac Odontol; 1990 Dec; (26):21-6. PubMed ID: 2134728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the diagnosis of oral premalignant and malignant lesions.
    Epstein JB; Zhang L; Rosin M
    J Can Dent Assoc; 2002 Nov; 68(10):617-21. PubMed ID: 12410942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukoplakia and erythroplakia of the oral mucosa--a brief overview.
    Boy SC
    SADJ; 2012 Nov; 67(10):558-60. PubMed ID: 23957095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer.
    Warnakulasuriya KA; Johnson NW
    J Oral Pathol Med; 1996 Mar; 25(3):97-103. PubMed ID: 9148038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of cancerous and precancerous lesions of the oral mucosa in an at-risk population].
    Vacher C; Legens M; Rueff B; Lezy JP
    Rev Stomatol Chir Maxillofac; 1999 Oct; 100(4):180-3. PubMed ID: 10599125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.